Comparison
Berberine vs Thymosin Alpha-1
Side-by-side of Berberine and Thymosin Alpha-1. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Berberine
Berberine supplement guide: 1500 mg/day lowers fasting glucose and HbA1c, AMPK activation, metformin parity in RCTs, dihydroberberine absorption.
Thymosin Alpha-1
Thymosin alpha-1 peptide (Zadaxin, thymalfasin): 28-amino-acid TA1 immunomodulator. Dosing, T-cell effects, hepatitis B and HCV adjunct evidence.
Effects at a glance
Berberine
- •Lowers HbA1c by ~0.7% versus placebo at 1500 mg/day across 27-trial meta-analysis (Lan 2015)
- •Roughly comparable to metformin on fasting glucose and HbA1c in small head-to-head RCTs (Yin 2008)
- •Reduces LDL cholesterol 10-20% and triglycerides 15-25% via PCSK9 inhibition
- •Activates AMPK, the cellular energy sensor that drives insulin-independent glucose uptake
- •Oral bioavailability under 1%; dihydroberberine is the higher-absorption alternative at lower doses
- •GI side effects affect 10-30% at 1500 mg/day; split dosing with meals reduces incidence
Thymosin Alpha-1
- •28-amino-acid synthetic peptide identical to thymic-derived immunomodulator
- •Approved in over 35 countries as Zadaxin for hepatitis B, hepatitis C adjunct, and immune support
- •Not FDA approved in US; compounded by 503A/503B pharmacies for off-label immune support
- •Modulates T-cell maturation, NK activity, and Th1 polarization in immunocompromised states
- •Standard label dose: 1.6 mg subcutaneously twice weekly
- •Cleanest safety profile in the peptide class with hundreds of regulated trials behind it
Side-by-side
| Attribute | Berberine | Thymosin Alpha-1 |
|---|---|---|
| Category | natural | peptide |
| Also known as | berberine HCl, berberine hydrochloride | Talpha1, Ta1, Zadaxin, Thymalfasin |
| Half-life (hr) ↗ | 3 | 2 |
| Typical dose (mg) ↗ | 1500 | 1.6 |
| Dosing frequency | 3x daily with meals | 2x weekly |
| Routes | oral | subcutaneous, intramuscular |
| Onset (hr) | 2 | 24 |
| Peak (hr) | 3 | 168 |
| Molecular weight | 336.36 | 3108.32 |
| Molecular formula | C20H18NO4+ | C129H215N33O55 |
| Mechanism | Activates AMP-activated protein kinase (AMPK), suppressing hepatic gluconeogenesis and lipogenesis while increasing peripheral glucose uptake. Inhibits PCSK9 transcription, modulates bile acid signaling, and shifts gut microbiome composition. | Synthetic peptide modulator of innate and adaptive immunity. Promotes T-cell maturation and CD4/CD8 production, modulates Th1/Th2 balance, stimulates NK cell activity, and modulates TLR2/TLR9 signaling in dendritic cells. |
| Legal status | Dietary supplement (US, EU, UK, Canada); Rx in some Asian jurisdictions | Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List |
| WADA status | allowed | unknown |
| DEA / Rx | Not scheduled | Rx only via international approval or US compounding (no controlled-substance schedule) |
| Pregnancy | Contraindicated (kernicterus risk in neonates) | Not recommended; insufficient data |
| CAS | 2086-83-1 | 62304-98-7 |
| PubChem CID | 2353 | 16130571 |
| Wikidata | Q411435 | Q913854 |
Safety profile
Berberine
Common side effects
- constipation
- diarrhea
- abdominal cramping
- flatulence
- nausea
Contraindications
- pregnancy
- lactation
- neonatal jaundice
- severe liver disease
Interactions
- metformin: additive HbA1c reduction; additive GI side effects(moderate)
- insulin or sulfonylureas: additive hypoglycemia risk; dose adjustment may be required(major)
- statins (simvastatin, atorvastatin): CYP3A4 inhibition raises statin plasma levels(moderate)
- cyclosporine: raises cyclosporine levels through CYP3A4 and P-gp inhibition(major)
- calcium channel blockers (amlodipine): elevated plasma levels via CYP3A4 inhibition(moderate)
Thymosin Alpha-1
Common side effects
- mild injection-site irritation (rare)
- transient mild fatigue (rare)
- occasional headache (rare)
Contraindications
- pregnancy
- lactation
- active organ transplant rejection therapy
- systemic immunosuppression for autoimmune disease (relative)
- severe active autoimmune disease (caution)
Interactions
- interferon-alpha: additive immune effect; used clinically in approved combination protocols(minor)
- calcineurin inhibitors (cyclosporine, tacrolimus): theoretical destabilization of immunosuppression; avoid(major)
- antimetabolites (azathioprine, mycophenolate): theoretical destabilization of immunosuppression; avoid(major)
- vaccine administration: may augment vaccine response in elderly or immunocompromised; coordinate with clinician(minor)
Which Should You Take?
Berberine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Thymosin Alpha-1 is the right call when one of the conditionals below applies.
- → If your priority is metabolic health and glucose control, pick Berberine.
- → If your priority is healthspan extension, pick Berberine.
- → If your priority is immune support, pick Thymosin Alpha-1.
- → If your priority is post-training recovery, pick Thymosin Alpha-1.
Edge case: If you want to avoid Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List, Berberine is the more accessible choice.
Default choice: Berberine. Lower friction to source, and broader goal coverage. Reach for Thymosin Alpha-1 only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Berberine and Thymosin Alpha-1?
Berberine and Thymosin Alpha-1 differ in category (natural vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Berberine or Thymosin Alpha-1?
Berberine half-life is 3 hours; Thymosin Alpha-1 half-life is 2 hours.
Can you stack Berberine with Thymosin Alpha-1?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper